Literature DB >> 10353988

International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.

R J Lukas1, J P Changeux, N Le Novère, E X Albuquerque, D J Balfour, D K Berg, D Bertrand, V A Chiappinelli, P B Clarke, A C Collins, J A Dani, S R Grady, K J Kellar, J M Lindstrom, M J Marks, M Quik, P W Taylor, S Wonnacott.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10353988

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  149 in total

1.  N,N-disubstituted piperazines: synthesis and affinities at alpha4beta2(*) and alpha7(*) neuronal nicotinic acetylcholine receptors.

Authors:  Jianhong Chen; Seth Norrholm; Linda P Dwoskin; Peter A Crooks; Donglu Bai
Journal:  Bioorg Med Chem Lett       Date:  2003-01-06       Impact factor: 2.823

2.  Interactions of the M2delta segment of the acetylcholine receptor with lipid bilayers: a continuum-solvent model study.

Authors:  Amit Kessel; Turkan Haliloglu; Nir Ben-Tal
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

3.  Modulation of gain-of-function α6*-nicotinic acetylcholine receptor by β3 subunits.

Authors:  Bhagirathi Dash; Ronald J Lukas
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

4.  Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures.

Authors:  Cristian A Zambrano; Rakel M Salamander; Allan C Collins; Sharon R Grady; Michael J Marks
Journal:  J Pharmacol Exp Ther       Date:  2012-04-24       Impact factor: 4.030

5.  Negative allosteric modulators that target human alpha4beta2 neuronal nicotinic receptors.

Authors:  Brandon J Henderson; Ryan E Pavlovicz; Jerad D Allen; Tatiana F González-Cestari; Crina M Orac; Andrew B Bonnell; Michael X Zhu; R Thomas Boyd; Chenglong Li; Stephen C Bergmeier; Dennis B McKay
Journal:  J Pharmacol Exp Ther       Date:  2010-06-15       Impact factor: 4.030

6.  Chronic nicotine treatment differentially modifies acute nicotine and alcohol actions on GABA(A) and glutamate receptors in hippocampal brain slices.

Authors:  William R Proctor; Peter Dobelis; Anna T Moritz; Peter H Wu
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

7.  A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.

Authors:  Qiang Liu; Yao Huang; Fenqin Xue; Alain Simard; Jamie DeChon; Guohui Li; Jianliang Zhang; Linda Lucero; Min Wang; Michael Sierks; Gang Hu; Yongchang Chang; Ronald J Lukas; Jie Wu
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

Review 8.  Electrophysiological properties of NG2(+) cells: Matching physiological studies with gene expression profiles.

Authors:  Valerie A Larson; Ye Zhang; Dwight E Bergles
Journal:  Brain Res       Date:  2015-09-15       Impact factor: 3.252

9.  Alpha3beta4-nicotinic receptors mediate adrenergic nerve- and peptidergic (CGRP) nerve-dependent vasodilation induced by nicotine in rat mesenteric arteries.

Authors:  S Eguchi; S Miyashita; Y Kitamura; H Kawasaki
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

10.  Alkaloids from Microcos paniculata with cytotoxic and nicotinic receptor antagonistic activities.

Authors:  Patrick C Still; Bitna Yi; Tatiana F González-Cestari; Li Pan; Ryan E Pavlovicz; Hee-Byung Chai; Tran Ngoc Ninh; Chenglong Li; Djaja Djendoel Soejarto; Dennis B McKay; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2013-01-17       Impact factor: 4.050
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.